Mar 28, 2022 Press Releases BioSTL’s Labor Market Analysis Reveals Significant Opportunities for Accessible, Quality Jobs in Commercial Bioscience
Mar 23, 2022 In the News BioGenerator portfolio tops $2.5 billion in follow-on capital for St. Louis bioscience companies › BioSTL for St. Louis Business Journal
Mar 22, 2022 Press Releases St. Louis Agtech Ecosystem Partners Fund New Arch Grants AgriFoodTech Track
Mar 18, 2022 In the News, KMOX Nothing Impossible Nothing Impossible: BioGenerator Milestone › KMOX NewsRadio 1120
Mar 17, 2022 In the News BioGenerator-backed Wugen, which has raised $200M+ in VC funding, launches clinical trial for cancer drug › St. Louis Business Journal
Mar 14, 2022 In the News, Video On TV: President Biden’s Cancer Moonshot is Expected to Fund Innovative Treatments in St. Louis › HEC-TV
Mar 10, 2022 In the News The Brookings Institution: St. Louis is a 'Rising Star' › Brookings Institution
Mar 2, 2022 Press Releases BioGenerator Company Susterco and Impossible Sensing Enter Licensing Agreement